Physician profile
Ryan A Anthony
NPI 1295942647
$552.81
in general payments reported to CMS, 2019-2025
12 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.44 · 2020: $11.77 · 2021: $47.63 · 2023: $157 · 2024: $59.17 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.08 | 2023-2025 | Lifevest |
| Medtronic, INC. | $99.56 | 2023 | Corevalve Evolut R, Linq II, Micra |
| Stryker Corporation | $86.43 | 2025 | Gamma, Pangea, Variax |
| Astellas Pharma US INC | $41.02 | 2019 | |
| Pfizer INC. | $39.69 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.01 | 2019-2023 | Camzyos |
| Kestra Medical Technology Services, INC. | $29.89 | 2024 | Assure Wcd |
| Abbott Laboratories | $24.86 | 2021 | |
| Novo Nordisk INC | $23.28 | 2025 | Wegovy |
| Edwards Lifesciences Corporation | $22.77 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $18.45 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.